Infinium Pharmachem Ltd - Stock Valuation and Financial Performance

BSE: 0 | NSE: INFINIUM | Chemicals | Small Cap

BSE Share Price
Not Listed

DeciZen - make an informed investing decision on Infinium Pharmachem

Overall Rating
M-Cap below 500cr. High Risk from low Liquidity Bole Toh

1. Quality

2. Valuation

Undervalued

3. Price Trend

Semi Strong

Infinium Pharmachem stock performance -

mw4me loader
P/E Ratio (SA):
34.83
Market Cap:
318.7 Cr.
52-wk low:
0
52-wk high:
0

Is Infinium Pharmachem Ltd an attractive stock to invest in?

1. Is Infinium Pharmachem Ltd a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Infinium Pharmachem Ltd is a average quality company.

2. Is Infinium Pharmachem Ltd undervalued or overvalued?

The key valuation ratios of Infinium Pharmachem Ltd's currently when compared to its past seem to suggest it is in the Somewhat overvalued zone.

3. Is Infinium Pharmachem Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Semi Strong which suggest that the price of Infinium Pharmachem Ltd is likely to Rise-somewhat in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Infinium Pharmachem:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Infinium Pharmachem Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good

Value Creation

Value Creation Index Colour Code Guide

Mar'20Mar'21Mar'22Mar'23TTM
ROCE % 13.9%21.2%24.8%25.5%-
Value Creation
Index
0.00.50.80.8-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 3654.674101101
Sales YoY Gr.-51.4%35.7%36.8%-
Adj EPS 12.45.38.36.6
YoY Gr.-154.7%117.8%57.7%-
BVPS (₹) 4.36.912.321.338.8
Adj Net
Profit
12.55.48.59
Cash Flow from Ops. 2.36.89.17.4-
Debt/CF from Ops. 3.81.52.53.6-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NANA41.1%36.8%
Adj EPS NANA106%57.7%
BVPSNANA71.2%72.9%
Share Price - - - -

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'20Mar'21Mar'22Mar'23TTM
Return on
Equity %
22.443.454.749.421.9
Op. Profit
Mgn %
7.3911.815NAN
Net Profit
Mgn %
2.74.57.28.39
Debt to
Equity
2.11.51.81.2-
Working Cap
Days
01241381370
Cash Conv.
Cycle
05054680

Recent Performance Summary

Sales growth is growing at healthy rate in last 3 years 41.13%

Net Profit is growing at healthy rate in last 3 years 106.04%

Return on Equity has declined versus last 3 years average to 21.90%

Debt to equity has increased versus last 3 years average to 1.20

Sales growth is not so good in last 4 quarters at 0.00%

Latest Financials - Infinium Pharmachem Ltd.

Standalone Consolidated
TTM EPS (₹) 6.6 6.8
TTM Sales (₹ Cr.) 101 114
BVPS (₹.) 38.8 39.4
Reserves (₹ Cr.) 40 41
P/BV 5.90 5.81
PE 34.83 33.58
From the Market
52 Week Low / High (₹) 0.00 / 0.00
All Time Low / High (₹) - / -
Market Cap (₹ Cr.) 319
Equity (₹ Cr.) 13.9
Face Value (₹) 10
Industry PE 47

Management X-Ray of Infinium Pharmachem:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Infinium Pharmachem

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'20Mar'21Mar'22Mar'23
Sales365574101
Operating Expenses 33506586
Manufacturing Costs1233
Material Costs27395471
Employee Cost 2222
Other Costs 36711
Operating Profit 35915
Operating Profit Margin (%) 7.3%9.0%11.8%15.0%
Other Income 1111
Interest 1123
Depreciation 1111
Exceptional Items 0000
Profit Before Tax 14712
Tax 0123
Profit After Tax 1369
PAT Margin (%) 2.8%5.0%7.4%9.0%
Adjusted EPS (₹)1.02.75.49.0
Dividend Payout Ratio (%)0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'20Mar'21Mar'22Mar'23

Equity and Liabilities

Shareholders Fund 471322
Share Capital 1115
Reserves 361217
Minority Interest0000
Debt9112222
Long Term Debt66148
Short Term Debt35915
Trade Payables611109
Others Liabilities 1247
Total Liabilities 21314960

Fixed Assets

Gross Block78821
Accumulated Depreciation3345
Net Fixed Assets44416
CWIP 0480
Investments 0000
Inventories791418
Trade Receivables7101315
Cash Equivalents 0123
Others Assets2288
Total Assets 21314960

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'20Mar'21Mar'22Mar'23
Cash Flow From Operating Activity 2797
PBT 14712
Adjustment 2224
Changes in Working Capital -021-6
Tax Paid 0-1-2-3
Cash Flow From Investing Activity -1-5-7-3
Capex -1-5-5-5
Net Investments 0000
Others 00-22
Cash Flow From Financing Activity -1-1-2-3
Net Proceeds from Shares 0000
Net Proceeds from Borrowing 0000
Interest Paid -1-1-2-3
Dividend Paid 0000
Others 0000
Net Cash Flow 0102
PARTICULARSMar'20Mar'21Mar'22Mar'23
Ratios
ROE (%)23.5947.8756.1753.43
ROCE (%)19.8731.7734.4436.83
Asset Turnover Ratio1.752.131.861.85
PAT to CFO Conversion(x)22.331.50.78
Working Capital Days
Receivable Days75605851
Inventory Days68515658
Payable Days80807349

Infinium Pharmachem Ltd Stock News

Infinium Pharmachem Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Infinium Pharmachem on 01-Jan-1970 05:30 is ₹0.00.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 01-Jan-1970 05:30 the market cap of Infinium Pharmachem stood at ₹318.7.
The latest P/E ratio of Infinium Pharmachem as of 01-Jan-1970 05:30 is 34.83.
The latest P/B ratio of Infinium Pharmachem as of 01-Jan-1970 05:30 is 5.90.
The 52-week high of Infinium Pharmachem is ₹0.00 and the 52-week low is ₹0.00.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Infinium Pharmachem is ₹101.3 ( Cr.) .

About Infinium Pharmachem Ltd

The company was originally incorporated as ‘Infinium Pharmachem Private Limited’ on November 21, 2003 under the provisions of the Companies Act, 1956 vide Certificate of Incorporation issued by the Registrar of Companies, Ahmedabad, Gujarat. Later on, the company was converted into public limited company, the name of the company was changed to ‘Infinium Pharmachem Limited’ and fresh Certificate of Incorporation dated August 12, 2022 was issued by the Registrar of Companies, Ahmedabad, Gujarat.

The company was incorporated with the objective of manufacturing and supplying of various pharma related chemicals, bulk drugs, pharma intermediates etc. Accordingly, the company is dealing specifically and mainly in manufacturing and supplying of Iodine Derivatives, Pharma Intermediates and Active Pharmaceutical Ingredients (APIs). The company was formed with a vision to be globally integrated and admired Pharmaceutical & Healthcare Company.

The company undertakes Contract Research and Manufacturing Services (CRAMS) to provide customized and fully confidential solutions to its clients.  Currently, the company’s manufacturing capabilities and technical expertise have efficiently catered numerous industries such as Pharmaceutical & Biotech, Specialty & Performance Chemicals, Agrochemicals, Human Health, Animal Health, Cosmetics, Sanitation, Electrical, Electronics and much more. The company has auditable manufacturing facility and it has been audited by various well known pharma giants worldwide. The Company currently provides the widest range of Iodine derivatives in the market, with more than 250 intermediates and over 15 APIs. All its products are developed to meet challenging demands, superior quality, performance and various other commercial requirements across industries.

The company has developed and maintained long - term healthy relationships with all its clients, including Pharmaceutical, Biotech and Fine Chemical companies and its products reach out to over 250+ clients globally. The company formed a Subsidiary Company in the name of Infinium Green Energy Private Limited on June 06th, 2022, The Company also formed a foreign Subsidiary as a Joint Venture (JV) with Shanghai Witofly Chemical Co. Ltd., in the name of Shanghai Tajilin Industrial Co. Ltd., in the People's Republic of China in the year 2019.

Business area of the company

The company is well focused to Iodine chemistry & this is the only core area of it. It is working as CRAMS, but its domain is very restricted to Iodine chemistry & it revolves around Iodine derivatives or Iodination. It manufactures & supply wide range of superior quality Iodine Derivatives & API Since 2003. It is also providing fully integrated customized services from R&D to Commercial scale manufacturing and packaging for its products to the Pharmaceutical, Agrochemical, Nutraceutical, Speciality Chemicals & various other chemical Industries. It supplies range of Iodine derivatives on Order to Made basis only.

Major Events

  • 2003: Incorporation of the company viz. ‘Infinium Pharmachem Private Limited’.
  • 2022: Conversion of the company’s status from Private Limited to Limited Company.
Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.